- Report
- October 2024
- 182 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- April 2025
- 200 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- August 2024
- 169 Pages
Global
From €2283EUR$2,500USD£1,953GBP
- Report
- February 2025
- 182 Pages
Global
From €4110EUR$4,500USD£3,515GBP
- Report
- December 2024
- 100 Pages
United States
From €5434EUR$5,950USD£4,647GBP
- Report
- November 2024
- 81 Pages
United States
From €3197EUR$3,500USD£2,734GBP
- Report
- January 2024
- 193 Pages
Global
From €5434EUR$5,950USD£4,647GBP
- Report
- March 2024
- 200 Pages
Global
From €3790EUR$4,150USD£3,241GBP
- Report
- January 2024
- 278 Pages
Global
€4562EUR$4,995USD£3,901GBP
The Oral Solid Dosage Contract Manufacturing market is a subset of the Pharmaceutical Manufacturing industry. It involves the production of oral solid dosage forms, such as tablets, capsules, and powders, for pharmaceutical companies. This type of manufacturing is often outsourced to contract manufacturers, who specialize in the production of these products. Contract manufacturers provide a range of services, including formulation development, process optimization, and quality control. They also provide packaging and labeling services, as well as regulatory support. This type of manufacturing is highly regulated, and contract manufacturers must adhere to strict quality standards.
Some companies in the Oral Solid Dosage Contract Manufacturing market include Patheon, Recipharm, Catalent, and Aenova. Show Less Read more